248
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Cervical cancer vaccine: state of the art in prevention of human papillomavirus infection

Pages 133-134 | Published online: 10 Jan 2014

References

  • Franco EL, Harper DM. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine23, 2388–2394 (2005).
  • Munoz N, Bosch FX, De Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med.348(6), 518–527 (2003).
  • Greer CE, Wheeler CM, Ladner MB et al. Human papillomavirus (HPV) type distribution and serologic response to HPV type 6 virus-like particles in patients with genital warts. J. Clin. Microbiol.33(8), 2058–2063 (1995).
  • Li HX, Zhu WY, Xia MY. Detection with the polymerase chain reaction of human papillomavirus DNA in condyloma acuminata treated with CO2 laser and microwave. Int. J. Dermatol.34(3), 209–211 (1995).
  • Skjeldstad FE, Koutsky LA, for the Merck Phase 3 HPV Vaccine Steering Committee (Future III). Phase II trial of prophylactic quadrivalent HPV 6, 11, 16, 18 L1 virus-like particle (VLP) vaccine: prevention of cervical intraepithelial neoplasia (CIN)2/3 including adeno- and squamous cell carcinoma in situ (CIS). Presented at: Infectious Diseases Society of America. Late Breaker Session 66, LB-8A. San Francisco, CA, USA, October 7, 2005.
  • Munoz N. A review of the Phase III clinical data for the quadrivalent human papilloma virus vaccine (Gardasil®). Europ. J. Obstet. Gyn. Rep. Biol. doi:10.1016/j.ejogrb.2006.06.024. (2006).
  • Koutsky LA, Harper DM. Chapter 13. Current findings from prophylactic HPV trials. Vaccine24(Suppl. 3), S114–S121 (2006).
  • Frazer IH, Cox JT, Mayeaux EJ et al. Advances in prevention of cervical cancer and other human papillomavirus-related diseases. Pediatr. Infect. Dis. J.25(Suppl.), S65–S81 (2006).
  • Lentinen M, Herrero R, Mayaud P et al. Chapter 28. Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries. Vaccine24(Suppl. 3), S233–S241 (2006).
  • Franco EL, Bosch FX, Cuzick J et al. Chapter 29. Knowledge gaps and priorities for research of HPV infection and cervical cancer. Vaccine24(Suppl. 3), S242–S249 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.